Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Investor Grievance Report_March 31, 2024
April 18, 2024
Certificate under Reg 74(5) of SEBI DP Regulations_March 31, 2024
April 15, 2024
Intimation under Reg.30- Resignation of Independent Director
April 12, 2024
Intimation under Reg 30 SEBI (LODR)_Explanation for Delay
April 5, 2024
Trading Window Closure intimation_March 31, 2024
March 30, 2024
Intimation of Appeal filed_March 2024
March 27, 2024
Investor Roadshow Intimation_February 29, 2024
February 29, 2024
Press release- Orchid Pharma's Exblifep receives USFDA approval
February 23, 2024
Monitoring Agency Report_December 31, 2023
February 13, 2024
Newspaper Publication_Unaudited Financial Results_December 31, 2023
February 9, 2024
Investor Earning Call Recording_February 09, 2024 (2)
February 9, 2024
Investor Earning Call Recording_February 09, 2024
February 9, 2024
Outcome of Board Meeting_February 08, 2024
February 8, 2024
Investors Presentation Q3_December 31, 2023
February 8, 2024
Investors Earning Call Schedule_February 09, 2024
February 5, 2024
Intimation of Board Meeting_February 08, 2024
February 1, 2024
Previous
1
...
Next
9 / 36